Mondelēz International, Inc. has announced the appointment of Brian McNamara to the company’s board of directors, effective February 1. McNamara has served as CEO of Haleon plc (formerly GSK Consumer Healthcare) since May 2022. Previously, he led GSK’s Consumer Healthcare business.

“We are pleased to welcome Brian to our Board. His breadth and depth of expertise in all aspects of consumer products leadership—including supply chain, brand marketing, customer engagement, and more—will provide valuable insight and strategic input to our team,” said Dirk Van de Put, chairman and CEO of Mondelēz International.

Before joining GSK in 2015, McNamara held a variety of senior leadership positions for several global consumer products companies, including Novartis AG and The Procter & Gamble Company. He currently sits on Haleon’s Board of Directors, as well as the Board of Directors of the Consumer Goods Forum.

McNamara’s appointment expands the size of the company’s board to 11 members, 10 of whom are deemed independent, including McNamara.

Related: Mondelēz International makes progress towards 2050 net zero emissions goal